ENTITY
Genetron Holdings Ltd

Genetron Holdings Ltd (GTH US)

49
Analysis
Health Care • China
Genetron Holdings Limited operates as a biology company. The Company develops treatment for cancer. Genetron Holdings serves customers in China.
more
•09 Aug 2026 04:20

Primer: Genetron Holdings Ltd (GTH US) - Aug 2026

Privatization and Delisting: Genetron Holdings Ltd. completed a going-private transaction in March 2024 and is no longer listed on the Nasdaq...

Logo
90 Views
Share
•06 Nov 2020 09:55

Insights on China Genetic Testing Industry

This article analyzed China genetic testing industry in the perspective of favorable policy, market potential, future trend, investment trend in...

Logo
592 Views
Share
bearish•Mirxes
•15 May 2025 18:08

Mirxes IPO: Valuation Without Sensible Fundamentals

​Singapore biotech company Mirexes launches IPO in Hong Kong to raise up to $139m, but little fundamentals support the valuation, even in blue sky...

Logo
1.3k Views
Share
bullish•PropertyGuru
•23 May 2024 00:41

PropertyGuru (PGRU US): KKR/TPG Mulling a Buyout

The concentrated shareholder register would suggest that TPG/KKR would aim for irrevocable from the other three substantial shareholders,...

Logo
663 Views
Share
bullish•JSR Corp
•02 Apr 2024 07:00

(Mostly) Asia M&A, Mar 2024: Chilled & Frozen, TDCX, MMA Offshore, JSR, Roland DG, SciClone

For the month of March, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$4bn. The average premium for the new deals...

Logo
656 Views
Share
x